News & Updates

New drug applications approved by US FDA as of 01-15 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Younger age at psychiatric disorder onset, previous hospitalizations, longer hospital stay, and history of suicide attempts have been identified as risk factors for psychiatric rehospitalizations in a recent naturalistic study.

Researchers at the Chinese University of Hong Kong (CUHK) have launched a programme that enhance access to primary care pain services in the community through nongovernmental organization (NGO) networks and digital interventions.

Women with prior depression, regardless of the timing, are likely to experience symptoms of depression during perimenopause, according to a study.